# Development of Novel Clinical Endpoints in Intermediate AMD

> **NCT03349801** · — · ACTIVE_NOT_RECRUITING · sponsor: **Frank G. Holz** · enrollment: 718 (actual)

## Conditions studied

- Age Related Macular Degeneration (AMD)

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT03349801
- **Lead sponsor:** Frank G. Holz
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-03-26
- **Primary completion:** 2026-02-28
- **Final completion:** 2026-02-28
- **Target enrollment:** 718 (ACTUAL)
- **Last updated:** 2025-01-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03349801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03349801, "Development of Novel Clinical Endpoints in Intermediate AMD". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03349801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*